AU2004246837B2 - Orally-dispersible multilayer tablet - Google Patents

Orally-dispersible multilayer tablet Download PDF

Info

Publication number
AU2004246837B2
AU2004246837B2 AU2004246837A AU2004246837A AU2004246837B2 AU 2004246837 B2 AU2004246837 B2 AU 2004246837B2 AU 2004246837 A AU2004246837 A AU 2004246837A AU 2004246837 A AU2004246837 A AU 2004246837A AU 2004246837 B2 AU2004246837 B2 AU 2004246837B2
Authority
AU
Australia
Prior art keywords
tablet
layer
layers
mixture
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004246837A
Other languages
English (en)
Other versions
AU2004246837A1 (en
Inventor
Catherine Herry
Gael Lamoureux
Pascal Oury
Yann Prevost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0306900A external-priority patent/FR2855756B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of AU2004246837A1 publication Critical patent/AU2004246837A1/en
Application granted granted Critical
Publication of AU2004246837B2 publication Critical patent/AU2004246837B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AU2004246837A 2003-06-06 2004-06-04 Orally-dispersible multilayer tablet Ceased AU2004246837B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR03/06900 2003-06-06
FR0306900A FR2855756B1 (fr) 2003-06-06 2003-06-06 Comprime orodispersible multicouche
US10/610,668 US20040247677A1 (en) 2003-06-06 2003-06-30 Multilayer orodispersible tablet
US10/610,668 2003-06-30
PCT/FR2004/001400 WO2004110411A2 (fr) 2003-06-06 2004-06-04 Comprime orodispersible multicouche

Publications (2)

Publication Number Publication Date
AU2004246837A1 AU2004246837A1 (en) 2004-12-23
AU2004246837B2 true AU2004246837B2 (en) 2009-07-16

Family

ID=33554071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004246837A Ceased AU2004246837B2 (en) 2003-06-06 2004-06-04 Orally-dispersible multilayer tablet

Country Status (11)

Country Link
US (1) US8263126B2 (enExample)
EP (1) EP1631263B1 (enExample)
JP (1) JP2006527184A (enExample)
KR (1) KR101125268B1 (enExample)
AU (1) AU2004246837B2 (enExample)
BR (1) BRPI0411039A (enExample)
CA (1) CA2528249C (enExample)
IS (1) IS8197A (enExample)
MX (1) MXPA05013202A (enExample)
NO (1) NO337922B1 (enExample)
WO (1) WO2004110411A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
JP4996241B2 (ja) 2003-01-14 2012-08-08 ギリアード サイエンシーズ， インコーポレイテッド 組み合わせ抗ウイルス治療のための組成物および方法
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US20080187581A1 (en) * 2005-03-16 2008-08-07 Subhash Pandurang Gore Delivery System For Mulitple Drugs
TWI375560B (en) * 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
AU2007224229B2 (en) * 2006-03-06 2012-10-11 Pozen Inc. Dosage forms for administering combinations of drugs
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
DK2046300T3 (da) * 2006-08-04 2010-07-26 Ethypharm Sa Oralt desintegrerende multilagstablet
KR100816064B1 (ko) * 2006-08-16 2008-03-24 주식회사 케이티앤지 홍삼이 함유된 다중 정제 및 이의 제조방법
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
BRPI0700133A (pt) * 2007-01-29 2008-09-16 Incrementha P D & I Pesquisa D composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
CA2689594A1 (en) 2007-06-07 2008-12-11 Sato Pharmaceutical Co., Ltd. Film preparation with rapidly dissolving property and flexibility
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
US20120077888A1 (en) * 2009-03-26 2012-03-29 Royal College Of Surgeons In Ireland Orodispersible tablets
CN102396237B (zh) * 2009-04-14 2014-11-26 松下电器产业株式会社 影像显示装置、影像收看用眼镜以及具备这些的系统
CN102458117B (zh) * 2009-05-01 2015-11-25 阿普塔利斯医药科技公司 含有非阿片样和阿片样止痛药的组合的口腔崩解片组合物
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
FR2951945B1 (fr) * 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
SG10201707532WA (en) 2013-03-14 2017-10-30 3 In 1 Dental Pllc Compositions For Treatment Of Xerostomia And For Tooth Treatment
JP6548809B2 (ja) * 2016-02-25 2019-07-24 久光製薬株式会社 口腔内貼付剤の製造方法
US11116720B2 (en) * 2018-08-29 2021-09-14 Nanthealth, Inc. Ice pop medicament delivery system and method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236713A (en) * 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
WO1994006416A1 (en) * 1992-09-24 1994-03-31 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JP2000336027A (ja) * 1999-05-26 2000-12-05 Lion Corp 多層錠の剥離抑制方法
WO2003017985A1 (en) * 2001-08-23 2003-03-06 Cimex Ag Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001936A1 (fr) 1985-09-25 1987-04-09 Gerhard Gergely Pastille de desintegration et son procede de fabrication
JP2573969B2 (ja) * 1987-10-21 1997-01-22 帝國製薬株式会社 薬物断続放出性口腔内適用製剤
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
CA2128820A1 (en) 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
ATE195418T1 (de) 1993-12-10 2000-09-15 Fujisawa Pharmaceutical Co Kombiniertes antipyretisches und analgetisches arzneimittel
DK0922464T3 (da) * 1996-07-12 2005-06-06 Daiichi Seiyaku Co Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme
AU741821B2 (en) * 1997-03-11 2001-12-13 Arakis Limited Dosage forms comprising separate portions of R- and S-enantiomers
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US5912012A (en) 1997-09-06 1999-06-15 Carlin; Edward J. Effervescent systems with simplified packaging requirements
CA2322315C (en) 1998-03-06 2008-09-16 Eurand International S.P.A. Fast disintegrating tablets
AU4802099A (en) 1998-07-28 2000-02-21 Takeda Chemical Industries Ltd. Rapidly disintegrable solid preparation
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
DE60124895D1 (de) 2001-07-26 2007-01-11 Ethypharm Sa Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
FR2855756B1 (fr) 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236713A (en) * 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
WO1994006416A1 (en) * 1992-09-24 1994-03-31 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JP2000336027A (ja) * 1999-05-26 2000-12-05 Lion Corp 多層錠の剥離抑制方法
WO2003017985A1 (en) * 2001-08-23 2003-03-06 Cimex Ag Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Derwent Abstract Accession number: AN 2001-205140 & JP 2000 336027 A (LION CORP) 5 December 2000 *

Also Published As

Publication number Publication date
EP1631263B1 (fr) 2014-02-26
US8263126B2 (en) 2012-09-11
NO337922B1 (no) 2016-07-11
IS8197A (is) 2005-12-22
CA2528249C (fr) 2013-03-05
WO2004110411A3 (fr) 2005-08-18
BRPI0411039A (pt) 2006-07-11
AU2004246837A1 (en) 2004-12-23
US20070036861A1 (en) 2007-02-15
WO2004110411A2 (fr) 2004-12-23
KR20060028767A (ko) 2006-04-03
KR101125268B1 (ko) 2012-04-23
NO20056046L (no) 2005-12-19
CA2528249A1 (fr) 2004-12-23
JP2006527184A (ja) 2006-11-30
MXPA05013202A (es) 2006-03-09
EP1631263A2 (fr) 2006-03-08

Similar Documents

Publication Publication Date Title
AU2004246837B2 (en) Orally-dispersible multilayer tablet
JP5572616B2 (ja) 口腔内分散性多層錠剤
AU2005307052B2 (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
US20110081389A1 (en) Composition comprising a mixture of active principles, and method of preparation
US20110293715A1 (en) Pharmaceutical Formulation and Process for Its Preparation
HK1082195B (en) Orally-dispersible multilayer tablet
HK1154515A (en) Taste-masked multiparticulate pharmaceutical composition comprising a drug-containing core particle and a solvent-coacervated membrane
HK1087015B (en) Composition comprising a mixture of active principles, and method of preparation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired